EBMT AMGEN Clinical Fellowship Programme
** Deadline for 2008 applications
18th November 2007 **
- Introduction
- Centres interested in hosting a fellow
- Funding
- Eligibility
- Selection process
- Submission of applications
- Terms & Conditions of EBMT AMGEN Fellowship Awards
- Download
a pdf. document with the contents of this page
The EBMT is a non profit-organisation that aims to promote all aspects associated with the transplantation of haematopoietic stem cells from all donor sources and donor types including basic and clinical research, education, standardisation, quality control and accreditation of transplant procedures.
Through the EBMT AMGEN Clinical Fellowship Programme promising young physicians are offered the opportunity to work at higher educational institutions (HEI) outside their home country, to pursue research projects which will contribute to advances in clinical research and improve patient care.
With the financial support of AMGEN, the EBMT AMGEN Clinical Fellowship Programme will offer six clinical research fellowships in the period 2006 - 2008. The EBMT AMGEN Fellowships are aimed at promoting clinical and epidemiological research in the field of hemato-oncology. The programme is not designed to simply support the acquisition of standard clinical skills.
- Two one-year EBMT AMGEN Fellowships will be awarded each year from 2006 - 2008
- Each fellowship award shall be for 35,000€
- The fellowship award shall be transferred by the EBMT to the HEI hosting the fellow and is to be used to cover the salary costs and incidental expenses of physicians in receipt of an EBMT AMGEN Fellowship
In order to qualify for an EBMT AMGEN Fellowship applicants must:
- be no older than 35 years at the time of application
- hold a Masters degree or PhD
- have a min. of 2 yrs of experience in clinical practice in the field of medical hemato-oncology at the time of application
- work at a centre which is a member of the EBMT or be an Individual EBMT Member
- have excellent written and verbal communication skills
- be able to communicate effectively in the language of the HEI
- be supported in his/her application by an HEI
HEIs must:
- be an academic institution renowned in the field of medical hemato-oncology
- be a Full Member of the EBMT
- make an institutional commitment to supervise a clinical research project proposal developed in collaboration with the applicant
- prior to submission of the application, confirm that
the applicant can communicate effectively in the language of the HEI.
This includes the ability to communicate with patients.
NOTE: Generally the host institute cannot host two EBMT AMGEN Fellows at the same time; applicants should note this and discuss appropriate timing with possible supervisors.
The EBMT will identify appropriate HEIs interested in participating in the EBMT AMGEN Fellowship Programme. These institutions will be publicised amongst EBMT members and on the EBMT website. Interested applicants who meet the eligibility criteria must approach an identified HEI to discuss research proposals before submitting an application supported by the host institution.
Applications are submitted to the EBMT Fellowship Committee, which is composed of EBMT members with expertise in the field. The EBMT Fellowship Committee shall be responsible for the selection of EBMT AMGEN Fellows and the transfer of the Fellowship Award to the HEI. Committee members will act as mentors to selected fellows.
The key selection criteria, which will be taken into consideration by the selection committee, are:
- Both applicant and supporting HEI fulfil the eligibility
criteria
- Quality of applicant
- Quality of HEI
- Quality of the Supervisor at the HEI and the plan for Supervisor/Fellow
interaction
- A focus on patient-orientated and, ultimately, clinical research
- The originality and validity of the clinical research project and its
relevance to the field of haematopoietic stem cell transplantation (HSCT)
- Availability of extra institutional resources to support the proposed
project
Eligible candidates who have identified
a relevant HEI and research project should complete the EBMT
AMGEN Fellowship Application Form and submit the following supporting
documentation to the EBMT Secretariat by post or email: fellowships
ebmt.org
1. Abstract of proposed research project (300 words)
2. Detailed description of proposed project (maximum 5 pages), to include:
- Specific aims
- Background
- Project design
- Potential impact on the HSCT field
- Institutional environment and support (including background of the Supervisor and plan for Supervisor/Fellow interaction)3. Full details of the budget, including any other funding available to support the fellow or research project
4. A current CV and bibliography of the applicant
5. A covering letter setting out the applicant's motivation in applying for the fellowship
6. A letter of recommendation from the applicant's Department Head
7. A letter of agreement from the HEI wishing to host an EBMT AMGEN Fellow
application form (word)
Notes:
1. All documents and the Fellowship Application Forms must be completed in English. Incomplete submissions will not be accepted and submissions from non-members will be returned to the sender
2. The letter of recommendation from the applicant's Head of department should be sent by mail to:
EBMT Secretariat, Dept of Hematology
Hospital Clinic, Villarroel 170
Barcelona 08036
SPAIN3. For further information contact Stephen Marcos Jones:
fellowships
Tel: +34 93 454 9543
Fax: +34 93 453 1263
Terms & Conditions of EBMT AMGEN Fellowship Awards
| 1. | The HEI at which the EBMT AMGEN Fellow
is to be based shall be responsible for the payment to the fellow
of all employment-related expenses, including any compensation or
salary, benefits, taxes or other expenses associated with an employer-employee
relationship. The HEI is required to manage the award in such a way
as to provide the EBMT AMGEN Fellow with a monthly salary over the
term of the fellowship |
| 2. | The Supervisor at the HEI is responsible
for monitoring the progress of the research project and for liaising
with the EBMT Fellowship Committee |
| 3. | EBMT AMGEN Fellows will be encouraged
by the Supervisor to attend Fellows' annual meetings organised by,
or on behalf of, AMGEN. The purpose of such meetings is to share and
discuss research findings and the data and information generated during
their fellowship whether by oral or poster presentation |
| 4. | Within one month of expiration of the
research fellowship EBMT AMGEN Fellows are required to prepare a report
for submission to AMGEN and the EBMT Fellowship Committee, detailing:
(i) the research performed pursuant to the EBMT AMGEN Fellowship,
and (ii) the results of such research It is anticipated that the report
will lead onto the production of a manuscript of a standard suitable
for submission to a reputable peer reviewed journal. AMGEN will be
given the opportunity to review and comment on any manuscript submitted
for publication. Any publication will acknowledge that an EBMT AMGEN
Fellowship supported the research |
| 5. | The recipient is required to respond
to the EBMT's request for information on their career progress following
the Fellowship award |
| 6. | Recipients are responsible for submitting
their research findings for presentation at the Annual EBMT meeting
within two years following the ending of the grant period |
| 7. | EBMT AMGEN Fellowship Award recipients
are not insured by the EBMT or AMGEN for medical expenses, nor are
they insured for accidents during travel to and from the HEI and their
place of residence, or during their say. During the Fellowship, the
EBMT and AMGEN are not liable for the actions, activities, health,
or safety of the Fellows. In their own interest, award recipients
are advised to ensure that they, their dependants, and the institution
hosting them, have the necessary insurance coverage |
| 8. | EBMT is a non-profit organization and
it is the responsibility of the Fellows to pay any necessary taxes
required by their home/host country regarding the Fellowship |
